Clinical Trial Update: Study Comparing Two VAY736 Drug Products in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study comparing two VAY736 drug products in patients with Rheumatoid Arthritis; the trial status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• VAY736

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED